Jun 15, 2026 08:01AM
Jun 15, 2026 08:00AM
May 20, 2026 08:00AM
Apr 30, 2026 08:50AM
Apr 30, 2026 08:00AM
Apr 24, 2026 09:00AM
Apr 24, 2026 09:00AM Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn)
Mar 31, 2026 08:06AM
Mar 31, 2026 08:00AM
Nov 25, 2025 08:02AM
Nov 25, 2025 08:00AM
Nov 21, 2025 07:30AM
Nov 21, 2025 07:30AM
Nov 12, 2025 08:01AM Telomir reports Telomir-1 reduces cellular iron more than approved chelator
Nov 12, 2025 08:00AM
Jun 18, 2025 09:15AM
Jun 18, 2025 09:15AM
Jun 11, 2025 09:42AM
Jun 11, 2025 09:30AM
Jun 5, 2025 08:30AM
Jun 2, 2025 08:30AM Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform
May 29, 2025 08:43AM
May 29, 2025 08:30AM
May 21, 2025 09:03AM
May 21, 2025 09:00AM
May 7, 2025 08:04AM
May 7, 2025 08:00AM
Mar 19, 2025 08:03AM Telomir Pharmaceuticals (TELO) Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model
Mar 19, 2025 08:00AM
Feb 26, 2025 08:04AM
Feb 26, 2025 08:00AM
Feb 21, 2025 08:02AM
Feb 21, 2025 08:00AM
Feb 18, 2025 08:02AM
Feb 18, 2025 08:00AM Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)
Jan 28, 2025 08:02AM
Jan 28, 2025 08:00AM
Jan 7, 2025 08:02AM
Jan 7, 2025 08:00AM
Dec 23, 2024 07:32AM
Dec 23, 2024 07:30AM
Dec 12, 2024 08:33AM Telomir Pharmaceuticals (TELO) Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price
Dec 12, 2024 08:30AM
Dec 3, 2024 07:32AM
Dec 3, 2024 07:30AM
Nov 21, 2024 07:04AM
Nov 21, 2024 07:00AM
Sep 26, 2024 04:00PM
Sep 4, 2024 07:33AM Telomir Pharmaceuticals (TELO) Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo
Sep 4, 2024 07:30AM

323,112 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All